Ingram Micro Commerce & Lifecycle Services Adds Shipwire Logistics Platform to Sweden Warehouse
18.8.2021 07:00:00 EEST | Business Wire | Press release
Ingram Micro Commerce & Lifecycle Services, a leading provider of e-commerce fulfillment solutions and third-party logistics, today announced that Shipwire, the company’s e-commerce logistics platform, has been integrated into its warehouse in Borås, Sweden. Access to Shipwire enables online brands and retailers in the region to manage their operations through the cloud-based platform and ship to customers domestically and internationally.
Ingram Micro’s Shipwire-integrated warehouse in Borås is strategically located 63km from the Port of Gothenburg, the largest port in the Nordics, and 41km from the Gothenburg-Landvetter Airport. Additionally, its location along Route 40 between Gothenburg and Jönköpings makes Borås an important logistics hub within the region. Current clients are using the facility to ship domestically, regionally and overseas.
“With Shipwire newly available in our warehouse in Sweden, we are excited to offer our customers the opportunity to leverage the platform for e-commerce fulfillment throughout Europe,” said Marcelo Wesseler, vice president of e-commerce, Ingram Micro Commerce & Lifecycle Services. “Along with our operational capabilities in Sweden, we recently opened a new office in Berlin, a technology hub for Europe, and we look forward to building upon our legacy of serving Europe’s top e-commerce brands and retailers.”
E-commerce in the Nordics continues to grow and benefits from an economically strong consumer market. The region also boasts one of the most connected populations in the world, with Internet penetration at 94.5%, according to the World Bank. Ingram Micro has one other warehouse located in Sweden and its global network includes over 120 facilities.
About Ingram Micro Commerce & Lifecycle Services
Ingram Micro Commerce & Lifecycle Services provides global supply chain solutions that connect supply and demand. From cross-border fulfillment to dropship and returns management, IT asset disposition, re-marketing, distribution and more, our solutions drive growth across the commerce and technology markets. The company proudly serves customers ranging from fast-growing brands to Global 2000 enterprises and are dedicated to facilitating their success through our global warehousing network, world-class technology, strategic partnerships, and decades of experience. Learn more at www.ingrammicroservices.com.
About Shipwire
Shipwire, a cloud-based platform from Ingram Micro Commerce & Lifecycle Services, offers a comprehensive order management system that connects merchants to an expansive global network of warehouses, parcel carriers, transportation and ecommerce options. The platform’s logistics infrastructure supports B2B and B2C solutions and enables fast order fulfillment, inventory control and visibility, and optimized supply chain solutions. For more information, contact Shipwire at: www.shipwire.com/contact/.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210817005929/en/
Contact information
Press Contact
Lauren Jow
Global Brand Manager
Ingram Micro Commerce & Lifecycle Services
lauren.jow@ingrammicro.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Viz.ai Expands into Neurodegenerative Disease with Cortechs.ai Collaboration9.7.2026 16:00:00 EEST | Press release
Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced a collaboration with Cortechs.ai, a global leader in neuroimaging and quantitative analysis solutions, to integrate Cortechs.ai's NeuroQuant and NeuroQuant MS suite into the Viz.ai platform, expanding access to quantitative neuroimaging for hospitals and health systems across the U.S. This partnership marks Viz.ai's expansion into neurodegenerative disease, growing Viz Neuro Suite beyond its already market-leading neuro offerings. The collaboration will begin with a focus on multiple sclerosis (MS), integrating quantitative MRI analysis from NeuroQuant MS directly into Viz.ai's care coordination workflow, giving clinicians both the quantitative precision and the coordination infrastructure needed to identify and manage MS patients at scale. “Viz.ai's core mission has always been to increase access to life-saving treatments. It’s about getting the right information to the right care tea
Orca Security Report: 99.9% of Fixable AI Vulnerabilities Remain Unpatched as AI Moves Into Production9.7.2026 16:00:00 EEST | Press release
Orca Security, a leader in cloud and AI security, today released its 2026 State of AI Security Report, offering a first-hand view into how AI is being deployed across more than 1,200 production cloud environments. The findings show AI is no longer limited to isolated pilots or developer experiments. Organizations are embedding AI into production applications, cloud services, and autonomous workflows faster than security programs can adapt. More than half (56%) of organizations have already deployed AI agents into production, while 51% use AI to build custom applications. At the same time, Orca found that 81% of organizations run vulnerable AI packages, and 99.9% of fixable AI vulnerabilities remain unpatched, highlighting how quickly AI has become operational infrastructure without corresponding security maturity. The report also reveals that AI environments are rapidly becoming more interconnected and business critical. Among organizations adopting AI, 64% now run vector databases, 55
Echodyne Opens New Manufacturing Facility to Meet Surging Global Demand for Advanced MESA® Radar9.7.2026 16:00:00 EEST | Press release
As governments around the world accelerate investment in counter-unmanned aircraft systems (C-UAS) and short-range air defense, Echodyne today announced the opening of a new advanced radar manufacturing facility in Washington State, significantly expanding its manufacturing capacity to meet rapidly growing demand from U.S. and allied customers. With millions of drones manufactured and used by both sides in the Russian War in Ukraine, the need for enhanced safety for defense, national security, and critical infrastructure assets grows with every successful strike and interception. The low cost and high utility of drones dramatically alters the need for safety and security sensors. And as the low altitude economy takes off, hundreds of thousands of drones will perform a range of life-saving and commercial missions, requiring a sensor infrastructure to monitor airspace activity. The new 86,350-square-foot facility is a major step in readying supply for multiple, large, global markets. The
SCP Standard Capital Partners AG: Fabian Becker Appointed Chairman of the Management Board and CEO9.7.2026 15:51:00 EEST | Press release
The Supervisory Board of SCP Standard Capital Partners AG (WKN: A12UPJ | ISIN: DE000A12UPJ7 | XETRA ticker: CAP) resolved today to appoint Mr. Fabian Becker as Chairman of the Management Board and Chief Executive Officer (CEO), effective as of 9 July 2026. Ms. Stephanie Schettler-Köhler will remain a member of the Management Board and will assume the role of Chief Operating Officer (COO). View source version on businesswire.com: https://www.businesswire.com/news/home/20260709982268/en/
Teva and Polpharma Biologics Announce Global Licensing Agreement for a Biosimilar Candidate to Ocrevus ® (ocrelizumab) for Multiple Sclerosis9.7.2026 15:45:00 EEST | Press release
Teva Pharmaceuticals International GmbH, a subsidiary of Teva Pharmaceutical Industries Ltd (NYSE: and TASE: TEVA) and Polpharma Biologics International AG today announced a global licensing agreement granting Teva exclusive rights to commercialize both formulations of Polpharma Biologics’ proposed biosimilar to Ocrevus®1 (ocrelizumab), upon regulatory approval. This strategic agreement is expected to combine Polpharma Biologics’ proven biosimilar development expertise with Teva’s commercial footprint and capabilities. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260709701277/en/ “This agreement reflects our focus on pushing high-quality biologics to the finish line efficiently and at scale,” said Anjan Selz, Chief Executive Officer of Polpharma Biologics International AG. “Teva brings reach, discipline and real commercial strength to our strategic collaboration. Combining its global footprint with our technical and develo
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom